Mabylon AG, a private Swiss biotech company, is leading innovation in antibody-based treatments for severe allergies, inflammation, and neurological disorders. Our B-cell screening platform identifies natural human antibodies with high specificity and therapeutic potential. MY006, our first-in-class multispecific antibody therapeutic for peanut allergy, is tackling the growing food allergy market.
View Top Employees from Mabylon AG| Website | http://www.mabylon.com |
| Revenue | $1 million |
| Employees | 20 (19 on RocketReach) |
| Founded | 2015 |
| Address | Wagistrasse 14, Schlieren, Zurich 8952, CH |
| Phone | +41 44 731 94 09 |
| Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Science and Engineering, Healthcare, Therapeutics, Health Care |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies |
Looking for a particular Mabylon AG employee's phone or email?
Mabylon AG Questions
The Mabylon AG annual revenue was $1 million in 2024.
Niccolo Pengo is the Chief Scientific Officer of Mabylon AG.
19 people are employed at Mabylon AG.
Mabylon AG is based in Schlieren, Zurich.
The NAICS codes for Mabylon AG are [541713, 54, 5417, 541, 54171].
The SIC codes for Mabylon AG are [873, 87].
Top Mabylon AG Employees
-
15
-
32
-
1
-
1
-
1
-
2
-
1
Related Companies
